Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

MLA

Osorio, A., et al. “Evaluation of a Candidate Breast Cancer Associated SNP in ERCC4 as a Risk Modifier in BRCA1 and BRCA2 Mutation Carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).” British Journal of Cancer, 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1247355164&authtype=sso&custid=ns315887.

APA

Osorio, A., Milne, R. L., Pita, G., Peterlongo, P., Heikkinen, T., Simard, J., Chenevix-Trench, G., Spurdle, A. B., Beesley, J., Chen, X., Healey, S., Neuhausen, S. L., Ding, Y. C., Couch, F. J., Wang, X., Lindor, N., Manoukian, S., Barile, M., Viel, A., … Johannsson, O. T. (2009). Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). British Journal of Cancer.

Chicago

Osorio, A., R.L. Milne, G. Pita, P. Peterlongo, T. Heikkinen, J. Simard, G. Chenevix-Trench, et al. 2009. “Evaluation of a Candidate Breast Cancer Associated SNP in ERCC4 as a Risk Modifier in BRCA1 and BRCA2 Mutation Carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).” British Journal of Cancer. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1247355164&authtype=sso&custid=ns315887.